Literature DB >> 33916000

Big Data in Studying Acute Pain and Regional Anesthesia.

Lukas M Müller-Wirtz1,2, Thomas Volk1,2.   

Abstract

The digital transformation of healthcare is advancing, leading to an increasing availability of clinical data for research. Perioperative big data initiatives were established to monitor treatment quality and benchmark outcomes. However, big data analyses have long exceeded the status of pure quality surveillance instruments. Large retrospective studies nowadays often represent the first approach to new questions in clinical research and pave the way for more expensive and resource intensive prospective trials. As a consequence, the utilization of big data in acute pain and regional anesthesia research has considerably increased over the last decade. Multicentric clinical registries and administrative databases (e.g., healthcare claims databases) have collected millions of cases until today, on which basis several important research questions were approached. In acute pain research, big data was used to assess postoperative pain outcomes, opioid utilization, and the efficiency of multimodal pain management strategies. In regional anesthesia, adverse events and potential benefits of regional anesthesia on postoperative morbidity and mortality were evaluated. This article provides a narrative review on the growing importance of big data for research in acute postoperative pain and regional anesthesia.

Entities:  

Keywords:  acute pain; anesthesia; anesthesiology; big data; database research; pain management; postoperative pain; regional analgesia; regional anesthesia; registries

Year:  2021        PMID: 33916000     DOI: 10.3390/jcm10071425

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

Review 1.  Interpreting and assessing confidence in network meta-analysis results: an introduction for clinicians.

Authors:  Alan Yang; Petros Pechlivanoglou; Kazuyoshi Aoyama
Journal:  J Anesth       Date:  2022-06-01       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.